Trump May Not Be Able To Fire Jerome Powell, Supreme Court Signals: Fed A 'Uniquely Structured, Quasi-Private Entity'
In a high-stakes ruling that expands presidential authority over independent federal agencies, the U.S. Supreme Court had one notable exception, the Federal Reserve.
Trump Administration Revokes Harvard's Ability To Enroll International Students, Kristi Noem Alleges Coordination With Chinese Communist Party
The Trump administration terminated Harvard University's ability to accept international students. This decision, announced on Thursday, affects current students who must transfer or risk losing their legal status.
Bitcoin Pizza Day Turns 15: How 10,000 BTC Could Have Bought Private Islands, Manhattan Penthouses And Some Of The World's Most Extravagant Luxuries Today
Bitcoin BTC/USD Pizza Day is here again, reminding us of the first commercial use of the prized digital currency. The event, celebrated each year on May 22, has become immortalized and serves as an important reminder of the cryptocurrency's humble beginnings.
Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition
VANCOUVER, British Columbia, May 22, 2025 ( GLOBE NEWSWIRE ) -- Algernon Pharmaceuticals Inc. ( the "Company" or "Algernon" ) ( CSE: AGN ) ( FRANKFURT: AGW0 ) ( OTCQB: AGNPF ) , a Canadian healthcare and clinical stage drug development company, is pleased to announce it has closed the ...
Algernon Closes NoBrainer Imaging Centers, Inc. Acquisition - Algernon Pharmaceuticals ( OTC:AGNPF )
VANCOUVER, British Columbia, May 22, 2025 ( GLOBE NEWSWIRE ) -- Algernon Pharmaceuticals Inc. ( the "Company" or "Algernon" ) AGN AGW AGNPF, a Canadian healthcare and clinical stage drug development company, is pleased to announce it has closed the acquisition to acquire 100% of the issued and ...
Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock
SAN DIEGO, May 22, 2025 ( GLOBE NEWSWIRE ) -- Gyre Therapeutics ( "Gyre" ) ( Nasdaq: GYRE ) , an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced the pricing of its previously announced underwritten public offering of 2,222,222 shares of its common ...
Gyre Therapeutics Announces Pricing of $20.0 Million Public Offering of Common Stock - Gyre Therapeutics ( NASDAQ:GYRE )
SAN DIEGO, May 22, 2025 ( GLOBE NEWSWIRE ) -- Gyre Therapeutics ( "Gyre" ) GYRE, an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced the pricing of its previously announced underwritten public offering of 2,222,222 shares of its common stock at a ...
APPLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Apple Inc. on Behalf of Apple Stockholders and Encourages Investors to Contact the Firm - Apple ( NASDAQ:AAPL )
NEW YORK, May 22, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Apple Inc. ( "Apple" or the "Company" ) AAPL on behalf of Apple stockholders.
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm - Fulgent Genetics ( NASDAQ:FLGT )
NEW YORK, May 22, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. ( "Fulgent" or the "Company" ) FLGT on behalf of Fulgent stockholders.
INTELLIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Intellia Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Intellia Therapeutics ( NASDAQ:NTLA )
NEW YORK, May 22, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Intellia Therapeutics, Inc.
